CSANDOMENICO, GFILIPPELLI, BMASSIDDA, AFARRIS, DNATALE, PALMERI S, et al. (2006). “Biweekly oxaliplatin plus capecitabine (OXXEL) versus oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus (OXAFAFU) in metastatic colorectal carcinoma (MCC): safety interim analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial”. In Proceedings Am Soc Clin Oncol (pp.168s-168s).
“Biweekly oxaliplatin plus capecitabine (OXXEL) versus oxaliplatin plus folinic acid-modulated 5-fluorouracil i.v. bolus (OXAFAFU) in metastatic colorectal carcinoma (MCC): safety interim analysis of a Southern Italy Cooperative Oncology Group (SICOG) phase III trial”
PALMERI, Sergio;
2006-01-01
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.